-
Ziprasidone HCl: From Receptors to Translation
2026-09-09
Ziprasidone HCl offers translational researchers a distinctive bridge between dopaminergic and serotonergic pharmacology, formulation science, and tumor-metabolism research. This article examines how ziprasidone hydrochloride can be evaluated as both a neuroscience tool and a reported GOT1-directed oncology research compound, with emphasis on assay design, permeability, and evidence boundaries.
-
DDI2–NFE2L1 Control of Ferroptosis
2026-09-09
The reference study shows that ferroptosis disrupts proteasome function and activates a DDI2-dependent NFE2L1 feedback response that restores protein quality control. Genetic loss or chemical inhibition of DDI2, including with nelfinavir, weakens this adaptation and sensitizes cells to ferroptotic death, identifying the pathway as a mechanistically defined target for further cancer and cell-death research.
-
Tamoxifen as a Precision Switch for Translational Biology
2026-09-08
Tamoxifen is more than an estrogen-pathway reagent: it is a context-dependent mechanistic probe and a temporal control tool for translational biology. This article connects conditional genetics with new evidence on persistent GZMK-expressing CD8+ T cells in recurrent airway inflammation.
-
Metronidazole for Reliable Cell Assays
2026-09-07
A scenario-based guide to using Metronidazole (SKU B1976) in viability, proliferation, transporter, and antimicrobial research. It explains concentration planning, solvent controls, assay interpretation, and practical criteria for selecting a well-characterized research reagent.
-
M344 in Neuroblastoma: Mechanism and Tumor Control
2026-09-07
The 2025 study evaluates M344 as a histone deacetylase inhibitor for neuroblastoma and connects increased histone acetylation with G0/G1 arrest, caspase-mediated cell death, reduced migration, and tumor-growth control. Its preclinical contribution is the integration of molecular, cellular, comparative, and combination-treatment evidence, including improved outcomes with metronomic dosing and selected chemotherapy combinations.
-
SB525334 for TGF-β1 Wound-Healing Studies
2026-09-05
SB525334 is a selective TGF-beta1 receptor inhibitor for testing how ALK5-dependent signaling separates reparative angiogenesis from pathological fibrosis. This article develops an assay framework linking Smad2/3 phosphorylation inhibition with spatial, temporal, and functional readouts in diabetic wound and renal disease models.
-
Staurosporine: Kinase Inhibitor & Apoptosis Tool
2026-09-04
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to interrogate kinase signaling and induce apoptosis in cancer research. Its activity against PKC isoforms, selected receptor tyrosine kinases, and VEGF-driven angiogenesis supports mechanistic studies, but its broad target profile requires pathway-specific controls.
-
Nicotine Signaling and Chronic Kidney Disease
2026-09-04
Jain and Jaimes present a mechanistic synthesis showing that nicotine may contribute directly to chronic kidney disease progression through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and fibrosis. The review is useful for researchers because it connects clinical observations with animal-model evidence while identifying experimental gaps in separating nicotine effects from those of the broader cigarette-smoke mixture.
-
Azithromycin and Roxithromycin as Senolytics
2026-09-04
The 2018 study by Ozsvari and colleagues used a fibroblast senolytic screening platform to identify azithromycin and roxithromycin as selective eliminators of senescent human cells, while closely related erythromycin was inactive. Its combination of viability screening, real-time impedance analysis, and metabolic measurements provides a useful framework for interpreting drug repurposing results while highlighting the limits of transferring findings across biological systems.
-
Staurosporine Workflows for Apoptosis Research
2026-09-03
Staurosporine combines broad kinase inhibition with a practical, reproducible route to apoptosis induction in cancer cell lines and signaling assays. This guide shows how to build concentration–time matrices, distinguish cell death modes, and use pathway readouts without overinterpreting a nonselective inhibitor.
-
15-PGDH Inhibition Preserves Muscle During Weight Loss
2026-09-02
A 2026 PNAS study identifies 15-PGDH inhibition as a strategy to improve muscle regeneration and force recovery during semaglutide-associated weight loss in obese mice. The work links a prostaglandin-degrading enzyme to muscle stem cell activity, regenerated myofiber growth, and postinjury muscle quality without reducing semaglutide’s weight-loss effect.
-
3-Bromopyruvate Reverses Cetuximab Resistance
2026-09-02
This 2023 Cancer Gene Therapy study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer cells that are intrinsically or adaptively resistant to cetuximab. The work links restored FOXO3a signaling to coordinated autophagy, ferroptosis, and apoptosis, providing a mechanistic framework for studying treatment resistance rather than relying on receptor targeting alone.
-
Staurosporine Workflows for Cancer Signaling
2026-09-01
Staurosporine combines broad kinase-pathway interrogation with a practical apoptosis workflow for 2D, 3D, and tumor-microenvironment models. This guide connects kinase inhibition to collagen-regulated breast cancer assays while emphasizing dose-finding, orthogonal readouts, and troubleshooting.
-
How NINJ1 Forms Membrane-Rupturing Nanodisc Rings
2026-09-01
The reference study proposes that NINJ1 drives plasma membrane rupture by assembling into nanodisc-like rings whose amphipathic helices reshape and pinch off lipid membranes. By combining cryo-EM, liposome reconstitution, live-cell imaging, and super-resolution microscopy, the authors distinguish NINJ1 membrane-disrupting activity from the related NINJ2 protein and connect molecular architecture with pyroptotic cell lysis.
-
Arachidonic Acid: From Lipid Signal to Stroke Strategy
2026-08-31
A translational framework for using Arachidonic Acid to interrogate eicosanoid biosynthesis, neuroinflammation, barrier injury, and therapeutic response in ischemia-reperfusion research.